Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.

The need for sensitive monitoring of minimal/measurable residual disease (MRD) in multiple myeloma emerged as novel therapies led to deeper responses. Moreover, the potential benefits of blood-based analyses, the so-called liquid biopsy is prompting more and more studies to assess its feasibility. C...

Full description

Bibliographic Details
Main Authors: Anita Marx, Magdolna Osváth, Bence Szikora, Orsolya Pipek, István Csabai, Ákos Nagy, Csaba Bödör, Zsolt Matula, Ginette Nagy, András Bors, Ferenc Uher, Gábor Mikala, István Vályi-Nagy, Imre Kacskovics
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0285696